Efficacy of a Psychoeducative Program for Improving Quality of Life in Fibromyalgic Patients [Study Protocol]
- Conditions
- Fibromyalgia
- Interventions
- Behavioral: Psychoeducative program in fibromyalgic patients
- Registration Number
- NCT00550966
- Lead Sponsor
- Institut Catala de Salut
- Brief Summary
This research project pretends to demonstrate that a psychoeducative program implemented in the context of PC can produce a significant increase in the quality of life of patients with FM, as well as a decrease in the use of sanitary and social services, compared to usual care.
- Detailed Description
Most fibromyalgic patients are attended at primary care (PC). However, the effectiveness of the treatments prescribed by general practitioners is usually scarce. The main objective of the present research is to assess the efficacy of a structured psychoeducative intervention, combined with relaxation, developed to improve the quality of life of patients suffering fibromyalgia (FM). The second objective is to assess the cost-effectiveness of this multimodal intervention.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 109
- Patients with aged between 18-75 years-old who meet the diagnostic criteria of fibromyalgia established by the American College of Rheumatology (ACR)
- Patients with a diagnosis not based on the ACR criteria
- Those with cognitive impairment or suffering from physical mental/psychiatric limitations
- Severe concurrent rheumatologic illness that impede participation in the study evaluations
- Those who are not expected to live at least 12 months
- Those without schooling.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Psychoeducative program in fibromyalgic patients Randomized controlled trial with a 12-month follow-up involving two groups, one of which is the intervention group that includes patients receiving a psychoeducative program and the other is the control group formed by patients treated for FM in the usual way. Setting. Three urban PC centers in the province of Barcelona (Spain) Sample. The total sample comprises 218 patients (over 18 years of age) suffering FM, selected from a database (Rheumatology service-Viladecans hospital) of patients with this illness. Only those patients introduced in the database between the years 2005 and 2007 are included in the selection. Selected patients are asked for written informed consent to participate in the study.
- Primary Outcome Measures
Name Time Method Quality of life is measured with the FIQ and the EuroQol-5D. 1, 2, 6 and 12 months later
- Secondary Outcome Measures
Name Time Method The use of sanitary services is measured with an adapted version of the Client Service Receipt Inventory (CSRI) 1, 2, 6 and 12 months later
Trial Locations
- Locations (1)
ABS Bartomeu Fabres Anglada. Institut Català de Salut.
🇪🇸Gava, Barcelona, Spain